These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33275687)

  • 21. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
    Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
    J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowering the prophylactic platelet transfusion threshold: a prospective analysis.
    Lawrence JB; Yomtovian RA; Hammons T; Masarik SR; Chongkolwatana V; Creger RJ; Manka A; Lazarus HM
    Leuk Lymphoma; 2001 Mar; 41(1-2):67-76. PubMed ID: 11342358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardization of prophylactic platelet transfusion dosing in a pediatric oncology population: a quality improvement project.
    Leibowitz M; Wolfe H; Flynn A; Waanders A; Burlingame C; Aumaier B; Friedman D; Lambert MP
    Transfusion; 2018 Dec; 58(12):2836-2840. PubMed ID: 30264395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An audit of platelet transfusion within the Wellington Cancer Centre.
    Buhrkuhl DC; Karlsson MK; Carter JM
    Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
    Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
    Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet transfusion in hematology, oncology and surgery.
    Wandt H; Schäfer-Eckart K; Greinacher A
    Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are thrombocytopenia and platelet transfusions associated with major bleeding in preterm neonates? A systematic review.
    Fustolo-Gunnink SF; Huisman EJ; van der Bom JG; van Hout FMA; Makineli S; Lopriore E; Fijnvandraat K
    Blood Rev; 2019 Jul; 36():1-9. PubMed ID: 30318111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
    Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
    Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
    Cornelissen LL; Caram-Deelder C; Fustolo-Gunnink SF; Groenwold RHH; Stanworth SJ; Zwaginga JJ; van der Bom JG
    Transfusion; 2021 Sep; 61(9):2578-2587. PubMed ID: 34263930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions.
    Bercovitz RS; O'Brien SH
    Hematology Am Soc Hematol Educ Program; 2012; 2012():157-60. PubMed ID: 23233575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial.
    Lye DC; Archuleta S; Syed-Omar SF; Low JG; Oh HM; Wei Y; Fisher D; Ponnampalavanar SSL; Wijaya L; Lee LK; Ooi EE; Kamarulzaman A; Lum LC; Tambyah PA; Leo YS
    Lancet; 2017 Apr; 389(10079):1611-1618. PubMed ID: 28283286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet transfusion: a clinical practice guideline from the AABB.
    Kaufman RM; Djulbegovic B; Gernsheimer T; Kleinman S; Tinmouth AT; Capocelli KE; Cipolle MD; Cohn CS; Fung MK; Grossman BJ; Mintz PD; O'Malley BA; Sesok-Pizzini DA; Shander A; Stack GE; Webert KE; Weinstein R; Welch BG; Whitman GJ; Wong EC; Tobian AA;
    Ann Intern Med; 2015 Feb; 162(3):205-13. PubMed ID: 25383671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy.
    Callow CR; Swindell R; Randall W; Chopra R
    Br J Haematol; 2002 Aug; 118(2):677-82. PubMed ID: 12139764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
    Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
    Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial.
    Uhl L; Assmann SF; Hamza TH; Harrison RW; Gernsheimer T; Slichter SJ
    Blood; 2017 Sep; 130(10):1247-1258. PubMed ID: 28679741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between platelet count and bleeding risk in thrombocytopenic patients.
    Slichter SJ
    Transfus Med Rev; 2004 Jul; 18(3):153-67. PubMed ID: 15248165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compliance with prophylactic platelet transfusion trigger in haematological patients.
    Eikenboom JC; van Wordragen R; Brand A
    Transfus Med; 2005 Feb; 15(1):45-8. PubMed ID: 15713128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.